Zobrazeno 1 - 10
of 610
pro vyhledávání: '"Dufilho, M."'
Publikováno v:
In Atherosclerosis 2006 187(2):285-291
Autor:
Jumeau, C, Rupin, A, Villeneuve, N, Mougenot, N, Ansaldi, J, Alessi, Mc, Hatem, S, David-Dufilho, M
Publikováno v:
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 30, pp.5-24, 2016, ⟨10.1111/fcp.12188⟩
Fundamental & Clinical Pharmacology, 30, pp.5-24, 2016, ⟨10.1111/fcp.12188⟩
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2d607a56b7073cb75f8824a81fce681
https://hal.science/hal-03949223
https://hal.science/hal-03949223
Autor:
Ren, Lu1 (AUTHOR) lu.ren@cchmc.org, Pushpakumar, Sathnur1 (AUTHOR), Almarshood, Hebah1 (AUTHOR), Das, Swapan K.2 (AUTHOR) sdas@wakehealth.edu, Sen, Utpal1 (AUTHOR) sdas@wakehealth.edu
Publikováno v:
International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 21, p11599. 27p.
Autor:
Alruhaimi, Reem S.1 (AUTHOR), Hussein, Omnia E.2 (AUTHOR), Alnasser, Sulaiman M.3 (AUTHOR), Germoush, Mousa O.4 (AUTHOR), Alotaibi, Meshal5 (AUTHOR), Hassanein, Emad H. M.6 (AUTHOR), El Mohtadi, Mohamed7 (AUTHOR), Mahmoud, Ayman M.8,9 (AUTHOR) a.mahmoud@mmu.ac.uk
Publikováno v:
Pharmaceuticals (14248247). Oct2024, Vol. 17 Issue 10, p1343. 18p.
Publikováno v:
Atherosclerosis
Atherosclerosis, Elsevier, 2006, 187 (2), pp.285-291. ⟨10.1016/j.atherosclerosis.2005.09.016⟩
Atherosclerosis, Elsevier, 2006, 187 (2), pp.285-291. ⟨10.1016/j.atherosclerosis.2005.09.016⟩
Background Although considered as an anti-inflammatory cytokine, interleukin-4 (IL-4) has been shown to be pro-atherogenic in mice models of atherosclerosis. Objectives In order to elucidate this paradox, we have investigated the effects of IL-4 on c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44b3e800640351f4f3dc9885ff5ee34b
https://hal.archives-ouvertes.fr/hal-02592306
https://hal.archives-ouvertes.fr/hal-02592306
Autor:
Friebel, Julian1,2,3 (AUTHOR) julian.friebel@dhzc-charite.de, Wegner, Max1 (AUTHOR) philipp.schencke@charite.de, Blöbaum, Leon1 (AUTHOR), Schencke, Philipp-Alexander1 (AUTHOR), Jakobs, Kai1 (AUTHOR), Puccini, Marianna1 (AUTHOR), Ghanbari, Emily1 (AUTHOR), Lammel, Stella1 (AUTHOR), Thevathasan, Tharusan1,3 (AUTHOR), Moos, Verena4 (AUTHOR), Witkowski, Marco1,5 (AUTHOR), Landmesser, Ulf1,2,3,5 (AUTHOR), Rauch-Kröhnert, Ursula1,2,5 (AUTHOR) ursula.rauch@dhzc-charite.de
Publikováno v:
International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 7, p4109. 18p.
Publikováno v:
Europe PubMed Central
To verify that platelet cytosolic pH is altered in essential hypertension and to investigate the mechanisms involved.Cytosolic pH was determined in unstimulated platelets by the fluorescent indicator 2,7-bis-carboxyethyl-5(6)-carboxyfluorescein (BCEC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c0cdf726425aed228416775b56466e62
https://pubmed.ncbi.nlm.nih.gov/1325518
https://pubmed.ncbi.nlm.nih.gov/1325518
Publikováno v:
Europe PubMed Central
Inhibition of the Na(+)-K+ pump by digitalis compounds has been reported to increase intracellular Na+ and Ca2+ concentrations and to stimulate Na(+)-H+ exchange. The activity of endogenous digitalis-like compounds, proposed to promote natriuresis an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::cbb88f20debdcd58253112881204a8ad
https://pubmed.ncbi.nlm.nih.gov/2165268
https://pubmed.ncbi.nlm.nih.gov/2165268
Publikováno v:
Diabetic Medicine; May1999, Vol. 16 Issue 5, p424-430, 7p